25 Years of DBS Innovation

Medtronic started developing deep brain stimulation in 1987 and has been the leader in the field ever since. Your Medtronic DBS will be backed by our decades of research, innovation, and experience.


GET TO KNOW MEDTRONIC

Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services, and solutions companies, serving physicians, hospitals, and patients in more than 160 countries. Medtronic medical devices include heart pacemakers, diabetes pumps, stents, surgical tools, and many others.


EXPANDING USES OF DBS

In the United States, the FDA has approved Medtronic DBS Therapy to treat some movement symptoms of Parkinson's disease and essential tremor. It is also approved under the Humanitarian Device Exemption* for treatment of dystonia and obsessive-compulsive disorder.


MILESTONES IN DBS

1987

First deep brain stimulation system implanted in Grenoble, France.

1997

FDA approves Medtronic DBS Therapy in the United States to treat essential tremor and tremor associated with Parkinson’s disease.

2002

FDA approves Medtronic DBS Therapy for the treatment of some of the symptoms of advanced Parkinson’s disease and MRI scans of the head only under certain conditions.

135,000 people have received Medtronic DBS Therapy for Parkinson's .

2015

FDA approves the use of MRI anywhere on the body with some Medtronic Activa DBS systems under certain conditions.**

2015

FDA approves the use of DBS Therapy for people who have had levodopa-responsive Parkinson's for at least 4 years and at least 4 months of movement symptoms not well controlled by medications or medication side effects such as unintended movements (dyskinesia). 


BACKED BY CLINICAL EVIDENCE

Medtronic DBS has been studied by clinical researchers for decades. DBS is not an experimental or brand-new medical treatment.

Only Medtronic DBS Therapy is supported by five Level 1 clinical studies—the highest quality of evidence.

Only the Medtronic DBS Therapy system has been rigorously assessed with Level 1 evidence and is FDA approved for people with Parkinson’s who had recent onset of movement symptoms as well as those with longer-standing movement symptoms.

Deep brain stimulation systems offered by other companies are approved only for patients with advanced Parkinson’s.


RIGOROUS TESTING FOR SAFE ACCESS TO MRI

We know it's important that you have safe** access to MRI if you need this important test to diagnose a medical condition or injury. That's why we performed rigorous testing:

  • 14 years of MRI research and testing
  • 10 million simulated patient scans performed using 38,800 scan conditions such as patient size and patient position within the MRI machine

We now offer the first full-body MR Conditional DBS systems, which means it is safe to have scans anywhere on the body with some Medtronic DBS devices under certain conditions.

All part of our continued development of deep brain stimulation.


*Humanitarian Device: Medtronic DBS Therapy has been authorized by Federal Law for the use as an aid in the management of chronic, intractable (drug refractory) primary dystonia and for people with chronic, severe, treatment-resistant obsessive-compulsive disorder. The effectiveness of this device for these uses has not been demonstrated.

**Medtronic DBS systems are MR Conditional which means they are safe for MRI scans only under certain conditions. If the conditions are not met, the MRI could cause tissue heating especially at the implanted lead(s) in the brain which may result in serious and permanent injury or death. Before having an MRI, always talk with the doctor who manages your DBS Therapy to determine your eligibility and discuss potential benefits and risks of MRI. For further information, please call Medtronic at 1-800-328-0810.

I'D LIKE TO STAY UPDATED ON WHAT'S NEW WITH PARKINSON'S AND MEDTRONIC DBS THERAPY.

JOIN US ON FACEBOOK
Content